# Cadrenal Therapeutics, Inc.: filings

CVKD · Nasdaq · CIK 1937993 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cvkd.md) · [Financials](/companies/cvkd/financials.md) · [Filings](/companies/cvkd/filings.md) · [Insiders](/companies/cvkd/insiders.md)

## Reports and events: 91 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 61, 4 57, 144 25, 10-Q 11, 3 10, CORRESP 10, UPLOAD 9, 424B5 8, EFFECT 8, D 7, 424B3 6, S-1/A 6, S-8 6, DEFA14A 5, 10-K 4, ARS 4, DEF 14A 4, S-3 4, SC 13G 4, S-1 3, 144/A 2, 424B4 2, DRS/A 2, DRSLTR 2, PRE 14A 2, SC 13G/A 2, SCHEDULE 13G/A 2, SEC STAFF LETTER 2, 3/A 1, 4/A 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, POS AM 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-07 | 13:23 ET | [8-K](/filings/0001213900-26-107442.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-107442 |
| 2026-09-29 | 20:05 ET | [8-K](/filings/0001213900-26-104647.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-104647 |
| 2026-08-31 | 12:29 ET | [8-K](/filings/0001213900-26-095394.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-095394 |
| 2026-08-13 | 20:31 ET | [10-Q](/filings/0001213900-26-089153.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089153 |
| 2026-08-13 | 20:30 ET | [8-K](/filings/0001213900-26-089147.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-089147 |
| 2026-08-03 | 21:09 ET | [DEF 14A](/filings/0001213900-26-084710.md) | Proxy statement, period 2026-09-24 | 0001213900-26-084710 |
| 2026-07-21 | 12:30 ET | [8-K](/filings/0001213900-26-079824.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-079824 |
| 2026-07-17 | 20:15 ET | [8-K](/filings/0001213900-26-079176.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-079176 |
| 2026-07-10 | 20:05 ET | [8-K](/filings/0001213900-26-077134.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-077134 |
| 2026-07-01 | 21:23 ET | [8-K](/filings/0001213900-26-074421.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-074421 |
| 2026-06-29 | 21:19 ET | [8-K](/filings/0001213900-26-073213.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-073213 |
| 2026-06-18 | 13:02 ET | [8-K](/filings/0001213900-26-069902.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-069902 |
| 2026-06-03 | 20:25 ET | [8-K](/filings/0001213900-26-064744.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-064744 |
| 2026-05-07 | 12:35 ET | [8-K](/filings/0001213900-26-053075.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-053075 |
| 2026-05-07 | 12:30 ET | [10-Q](/filings/0001213900-26-053074.md) | Quarterly report, period 2026-03-31 | 0001213900-26-053074 |
| 2026-04-30 | 12:40 ET | [8-K](/filings/0001213900-26-049754.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-049754 |
| 2026-04-01 | 11:40 ET | [8-K](/filings/0001213900-26-038014.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001213900-26-038014 |
| 2026-03-31 | 13:02 ET | [10-K](/filings/0001213900-26-036946.md) | Annual report, period 2025-12-31 | 0001213900-26-036946 |
| 2026-03-31 | 12:55 ET | [8-K](/filings/0001213900-26-036937.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-036937 |
| 2026-03-12 | 12:05 ET | [8-K](/filings/0001213900-26-026646.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-026646 |
| 2026-02-24 | 13:35 ET | [8-K](/filings/0001213900-26-019606.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-019606 |
| 2025-12-29 | 02:27 ET | [S-1](/filings/0001213900-25-125526.md) | Registration statement | 0001213900-25-125526 |
| 2025-12-23 | 21:58 ET | [8-K](/filings/0001213900-25-125433.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-125433 |
| 2025-12-16 | 13:24 ET | [8-K](/filings/0001213900-25-121932.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-121932 |
| 2025-12-11 | 13:17 ET | [8-K](/filings/0001213900-25-120360.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-120360 |
| 2025-12-01 | 14:05 ET | [8-K](/filings/0001213900-25-116307.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-116307 |
| 2025-11-18 | 21:23 ET | [8-K](/filings/0001213900-25-112123.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-112123 |
| 2025-11-10 | 14:05 ET | [8-K](/filings/0001213900-25-107949.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-107949 |
| 2025-11-10 | 11:21 ET | [10-Q](/filings/0001213900-25-107816.md) | Quarterly report, period 2025-09-30 | 0001213900-25-107816 |
| 2025-09-24 | 20:05 ET | [8-K](/filings/0001213900-25-091109.md) | 5.07 Shareholder vote results | 0001213900-25-091109 |
| 2025-09-15 | 13:53 ET | [8-K](/filings/0001213900-25-087461.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-087461 |
| 2025-08-11 | 20:52 ET | [8-K](/filings/0001213900-25-074355.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-074355 |
| 2025-08-11 | 10:09 ET | [10-Q](/filings/0001213900-25-073885.md) | Quarterly report, period 2025-06-30 | 0001213900-25-073885 |
| 2025-08-05 | 13:12 ET | [8-K](/filings/0001213900-25-071764.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-071764 |
| 2025-07-31 | 10:43 ET | [DEF 14A](/filings/0001213900-25-069612.md) | Proxy statement, period 2025-09-24 | 0001213900-25-069612 |
| 2025-07-18 | 20:49 ET | [8-K](/filings/0001213900-25-065710.md) | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-065710 |
| 2025-05-08 | 20:05 ET | [8-K](/filings/0001213900-25-041049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-041049 |
| 2025-05-08 | 10:17 ET | [10-Q](/filings/0001213900-25-040788.md) | Quarterly report, period 2025-03-31 | 0001213900-25-040788 |
| 2025-04-17 | 10:12 ET | [8-K](/filings/0001213900-25-032732.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-032732 |
| 2025-03-13 | 21:17 ET | [8-K](/filings/0001213900-25-023762.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-023762 |
| 2025-03-13 | 21:15 ET | [10-K](/filings/0001213900-25-023759.md) | Annual report, period 2024-12-31 | 0001213900-25-023759 |
| 2025-03-04 | 13:05 ET | [8-K](/filings/0001213900-25-019747.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-019747 |
| 2025-02-07 | 21:09 ET | [8-K](/filings/0001213900-25-011315.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-011315 |
| 2025-01-29 | 00:29 ET | [SCHEDULE 13D](/filings/0001213900-25-007997.md) | Ownership report, active investor | 0001213900-25-007997 |
| 2024-11-07 | 21:01 ET | [10-Q](/filings/0001213900-24-095393.md) | Quarterly report, period 2024-09-30 | 0001213900-24-095393 |
| 2024-11-07 | 14:10 ET | [8-K](/filings/0001213900-24-095195.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-095195 |
| 2024-11-04 | 21:41 ET | [8-K](/filings/0001213900-24-094155.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-094155 |
| 2024-10-24 | 13:10 ET | [8-K](/filings/0001213900-24-090153.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-090153 |
| 2024-09-25 | 20:05 ET | [8-K](/filings/0001213900-24-081799.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-081799 |
| 2024-09-05 | 20:59 ET | [8-K](/filings/0001213900-24-076144.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-24-076144 |

Page 1 of 2. [Older](/companies/cvkd/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.